21:29 EDT Correct: Theriva Biologics prices $2.5M public offering at $1.75 per share
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TOVX:
- Theriva Biologics Advances VCN-01 in VIRAGE Phase 2b Trial
- Theriva Biologics achieves target patient enrollment in VIRAGE Phase 2b trial
- Theriva Biologics Secures Funding for Viral Therapy Innovation
- Theriva Biologics awarded manufacturing funding from Spanish government
- Theriva Biologics files to sell 2.17M shares of common stock, warrants
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue